Advertisement
Advertisement

PTHS

PTHS logo

Pelthos Therapeutics Inc.

28.71
USD
Sponsored
-0.79
-2.68%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

28.81

+0.10
+0.35%

PTHS Earnings Reports

Positive Surprise Ratio

PTHS beat 3 of 7 last estimates.

43%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Pelthos Therapeutics Inc. earnings per share and revenue

On May 14, 2026, PTHS reported earnings of -3.09 USD per share (EPS) for Q1 26, beating the estimate of -3.34 USD, resulting in a 7.55% surprise. Revenue reached 10.91 million, compared to an expected 10.65 million, with a 2.36% difference. The market reacted with a +6.46% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Pelthos Therapeutics Inc. reported EPS of -$3.09, beating estimates by 7.55%, and revenue of $10.91M, 2.36% above expectations.
The stock price moved up 6.46%, changed from $26.01 before the earnings release to $27.69 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Pelthos Therapeutics Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement